Apixaban-Induced Resolution of A Massive Left Atrial and Appendage Thrombosis in a Very Elderly Patient.

about

Apixaban-Induced Resolution of A Massive Left Atrial and Appendage Thrombosis in a Very Elderly Patient.

Item

http://www.wikidata.org/entity/Q47245138

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@en

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@nl

type

Item

label

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@en

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@nl

prefLabel

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@en

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@nl

P1476

Apixaban-Induced Resolution of ...... sis in a Very Elderly Patient.

@en

P2093

Alfonso Ielasi

http://www.w3.org/2001/XMLSchema#string

Francesco Pattarino

http://www.w3.org/2001/XMLSchema#string

Gloria Santangelo

http://www.w3.org/2001/XMLSchema#string

Maurizio Tespili

http://www.w3.org/2001/XMLSchema#string

Pasquale Antonio Scopelliti

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?

Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.

Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.

Resolution of left atrial appendage thrombus with apixaban

Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study.

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

P304

1509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4022/JAFIB.1509

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250263

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

5673322

http://www.w3.org/2001/XMLSchema#string